IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aclaris Therapeutics, Inc.

CUSIP: 000COMMON | 1 institutional holders

Quarters

Q4 2019Q3 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2019

Vivo Capital, LLC101,392,395
72.8% of portfolio›$1,000.0K
StyleTurnoverLocationFiled
Vivo Capital, LLC
101,392,395$1,000.0K72.8%CoreMediumPalo Alto, CA2020-02-25